The Republic of Iceland – Government Debt Management
| Series | RIKS 26 0216 | RIKS 33 0321 | ||||
| Settlement Date | 03/10/2021 | 03/10/2021 | ||||
| Total Amount Allocated (MM) | 648 | 1,100 | ||||
| All Bids Awarded At (Price / Yield) | 108.135 | / | -0.140 | 121.700 | / | 1.068 |
| Total Number of Bids Received | 5 | 4 | ||||
| Total Amount of All Bids Received (MM) | 648 | 1,100 | ||||
| Total Number of Successful Bids | 5 | 4 | ||||
| Number of Bids Allocated in Full | 5 | 4 | ||||
| Lowest Price / Highest Yield Allocated | 108.135 | / | -0.140 | 121.700 | / | 1.068 |
| Highest Price / Lowest Yield Allocated | 108.448 | / | -0.200 | 122.563 | / | 1.000 |
| Lowest Price / Highest Yield Allocated in Full | 108.135 | / | -0.140 | 121.700 | / | 1.068 |
| Weighted Average of Successful Bids (Price/Yield) | 108.270 | / | -0.166 | 121.841 | / | 1.057 |
| Best Bid (Price / Yield) | 108.448 | / | -0.200 | 122.563 | / | 1.000 |
| Worst Bid (Price / Yield) | 108.135 | / | -0.140 | 121.700 | / | 1.068 |
| Weighted Average of All Bids Received (Price / Yield) | 108.270 | / | -0.166 | 121.841 | / | 1.057 |
| Percentage Partial Allocation (Approximate) | 100.00 % | 100.00 % | ||||
| Bid to Cover Ratio | 1.00 | 1.00 | ||||
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
ONWARD Medical NV18.9.2025 07:30:00 CEST | Press release
Concurrent Publications in Nature and Nature Medicine Highlight Advances in Blood Pressure Regulation after Spinal Cord Injury Using ONWARD ARC-IM Therapy
Sampo plc18.9.2025 07:30:00 CEST | Press release
Sampo plc’s share buybacks 17 September 2025
Biotalys NV18.9.2025 07:00:00 CEST | Press release
Biotalys Reports Half-Year 2025 Financial Results and Business Highlights
F. Hoffmann-La Roche Ltd18.9.2025 07:00:00 CEST | Press release
Roche enters into a definitive merger agreement to acquire 89bio, and its phase 3 FGF21 analog for the therapy of moderate to severe MASH
Ascom Holding AG18.9.2025 06:30:00 CEST | Press release
Michael Reitermann takes over the operational leadership of the Ascom Group as Delegate of the Board of Directors and interim CEO
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom